US$ 28.00
telehealth glp-1 Is Changing Fast Can You Safely Use GLP-1
Description
20, 2024, the FDA approved tirzepatide (Zepbound) for the treatment of moderate-to-severe OSA in adults with obesity, with and without positive airway pressure (PAP) therapy, making it the first GLP-1 indicated for OSA

The most effective way to decide is to consult with a dedicated weight loss specialist who can review your health profile and outline a customized plan

The manufacturer claims that 83% of adults taking Trimova lost 15% or more weight, and 48% of users lost at least 35% of their body weight

doi: 10.1016/j.diabres.2021.109080
